| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1104137893 |
| P356 | DOI | 10.1186/S12931-018-0804-1 |
| P932 | PMC publication ID | 5963077 |
| P698 | PubMed publication ID | 29784046 |
| P2093 | author name string | Jing Li | |
| Jian Zhou | |||
| Jie Hu | |||
| Chunxue Bai | |||
| Tao Fang | |||
| Meijia Chang | |||
| P2860 | cites work | Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 |
| EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib | Q24561953 | ||
| Annexin-A5 assembled into two-dimensional arrays promotes cell membrane repair | Q27667441 | ||
| MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling | Q27851406 | ||
| Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial | Q27851712 | ||
| Annexin V inhibits the 12-O-tetradecanoylphorbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells. | Q53408513 | ||
| Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort. | Q54340897 | ||
| Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. | Q27853162 | ||
| Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 | ||
| Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR | Q29547545 | ||
| The quest to overcome resistance to EGFR-targeted therapies in cancer | Q33725976 | ||
| Escape of U251 glioma cells from temozolomide-induced senescence was modulated by CDK1/survivin signaling | Q33733121 | ||
| Identification of molecular target proteins in berberine-treated cervix adenocarcinoma HeLa cells by proteomic and bioinformatic analyses | Q34239927 | ||
| Advances on EGFR mutation for lung cancer | Q35200375 | ||
| Annexin-A5 promotes membrane resealing in human trophoblasts. | Q35543998 | ||
| The role of annexin A5 in the modulation of the immune response against dying and dead cells | Q36737880 | ||
| Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications | Q36798851 | ||
| Annexin A5: shifting from a diagnostic towards a therapeutic realm | Q36944759 | ||
| Physical Proximity of Sister Chromatids Promotes Top2-Dependent Intertwining | Q37341759 | ||
| Annexin A5 as a potential marker in tumors | Q38152191 | ||
| Acquired resistance to TKIs in solid tumours: learning from lung cancer | Q38224967 | ||
| Review: Annexin-A5 and cell membrane repair. | Q38363318 | ||
| High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma | Q38708346 | ||
| A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines. | Q38720703 | ||
| Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin | Q38742701 | ||
| Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints | Q39029651 | ||
| The molecular mechanisms of chemoresistance in cancers | Q41709101 | ||
| The G2 checkpoint-a node-based molecular switch | Q42231430 | ||
| ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase | Q44082647 | ||
| PLK1 Activation in Late G2 Sets Up Commitment to Mitosis | Q47316004 | ||
| Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas | Q47746860 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P304 | page(s) | 96 | |
| P577 | publication date | 2018-05-21 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest. | |
| P478 | volume | 19 |
Search more.